128 related articles for article (PubMed ID: 7115951)
21. Bactericidal mechanisms of the granulocyte.
Spitznagel JK
Prog Clin Biol Res; 1977; 13():103-31. PubMed ID: 193132
[TBL] [Abstract][Full Text] [Related]
22. [Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo].
Labro MT; Bryskier A; Babin-Chevaye C; Hakim J
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):711-4. PubMed ID: 2847106
[TBL] [Abstract][Full Text] [Related]
23. Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide.
Condino-Neto A; Muscará MN; Grumach AS; Carneiro-Sampaio MM; De Nucci G
Br J Clin Pharmacol; 1993 May; 35(5):485-90. PubMed ID: 8390277
[TBL] [Abstract][Full Text] [Related]
24. The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity.
Mandell GL; Rubin W; Hook EW
J Clin Invest; 1970 Jul; 49(7):1381-8. PubMed ID: 4393490
[TBL] [Abstract][Full Text] [Related]
25. Monocyte function in patients with chronic granulomatous disease of childhood.
Donowitz GR; Mandell GL
Blood; 1982 Nov; 60(5):1151-8. PubMed ID: 7126869
[TBL] [Abstract][Full Text] [Related]
26. Effects of subinhibitory antibiotics on bactericidal activity of chronic granulomatous disease granulocytes in vitro.
Silva J; Dembinski S; Schaberg D
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():21-7. PubMed ID: 6643339
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil activity in chronic granulomatous disease.
Pak V; Budikhina A; Pashenkov M; Pinegin B
Adv Exp Med Biol; 2007; 601():69-74. PubMed ID: 17712993
[TBL] [Abstract][Full Text] [Related]
28. A simultaneous flow cytometric measurement of neutrophil phagocytosis and oxidative burst in whole blood.
Trinkle LS; Wellhausen SR; McLeish KR
Diagn Clin Immunol; 1987; 5(2):62-8. PubMed ID: 3621481
[TBL] [Abstract][Full Text] [Related]
29. Comparison of myeloperoxidase activity in leukocytes from normal subjects and patients with chronic granulomatous disease.
Pegram PS; DeChatelet LR; McCall CE
J Infect Dis; 1978 Nov; 138(5):699-702. PubMed ID: 213506
[TBL] [Abstract][Full Text] [Related]
30. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency.
Ganz T; Metcalf JA; Gallin JI; Boxer LA; Lehrer RI
J Clin Invest; 1988 Aug; 82(2):552-6. PubMed ID: 2841356
[TBL] [Abstract][Full Text] [Related]
31. Disorders of stimulus-response coupling in neutrophils.
Smolen JE; Boxer LA
Clin Lab Med; 1983 Dec; 3(4):779-800. PubMed ID: 6317279
[TBL] [Abstract][Full Text] [Related]
32. Effects of ascorbic acid on neutrophil function. Studies on normal and chronic granulomatous disease neutrophils.
Patrone F; Dallegri F; Bonvini E; Minervini F; Sacchetti C
Acta Vitaminol Enzymol; 1982; 4(1-2):163-8. PubMed ID: 7124564
[TBL] [Abstract][Full Text] [Related]
33. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils.
Ellis JA; Mayer SJ; Jones OT
Biochem J; 1988 May; 251(3):887-91. PubMed ID: 2843166
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte abnormalities.
Gabig TG
Med Clin North Am; 1980 Jul; 64(4):647-66. PubMed ID: 6995728
[TBL] [Abstract][Full Text] [Related]
35. Chronic granulomatous disease in an adult.
Nerurkar LS; Jacob A; Zeligs B; Walser J; Yeager H; Bellanti JA
South Med J; 1987 Oct; 80(10):1296-302. PubMed ID: 3660045
[TBL] [Abstract][Full Text] [Related]
36. Kinetics and mechanism of the bactericidal action of human neutrophils against Escherichia coli.
Hamers MN; Bot AA; Weening RS; Sips HJ; Roos D
Blood; 1984 Sep; 64(3):635-41. PubMed ID: 6087960
[TBL] [Abstract][Full Text] [Related]
37. Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes.
Ingraham LM; Boxer LA; Haak RA; Baehner RL
Blood; 1981 Oct; 58(4):830-5. PubMed ID: 7272511
[TBL] [Abstract][Full Text] [Related]
38. A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils. Evidence from studies with cells from patients with chronic granulomatous disease.
Hayakawa T; Suzuki K; Suzuki S; Andrews PC; Babior BM
J Biol Chem; 1986 Jul; 261(20):9109-15. PubMed ID: 3087987
[TBL] [Abstract][Full Text] [Related]
39. Improvement of polymorphonuclear leucocyte oxidative and bactericidal functions in chronic granulomatous disease with 4-amino-4'-hydroxylaminodiphenyl sulphone.
Ismail G; Boxer LA; Allen JM; Baehner RL
Br J Haematol; 1978 Oct; 40(2):219-29. PubMed ID: 708642
[TBL] [Abstract][Full Text] [Related]
40. Amantadine in chronic granulomatous disease.
Granzotto M; Leone V; Lepore L; Zerial M; Tommasini A; Ciambra R; Gombac F; Ventura A
Pediatr Hematol Oncol; 2005 Mar; 22(2):147-51. PubMed ID: 15805000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
